|
|||
2011-02-07 17:15:00 CET 2011-02-07 17:15:29 CET REGULATED INFORMATION Biotie Therapies - Changes board/management/auditorsOrganizational meeting of the Board of Directors of Biotie Therapies Corp.BIOTIE THERAPIES CORP. STOCK EXCHANGE RELEASE 7 February 2011, at 6.15 p.m. Organizational meeting of the Board of Directors of Biotie Therapies Corp. Board of Directors of Biotie Therapies Corp. ("Biotie" or the "Company") held its organizational meeting on 7 February 2011. Peter Fellner continues as the Chairman of the Board of Directors. The Board elected Bradley J. Bolzon as Deputy Chairman of the Board. The Board resolved that the Company shall continue to have two committees, Audit Committee as well as Nomination and Remuneration Committee. Members of the Audit Committee are Bernd Kastler (Chairman), Merja Karhapää, Piet Serrure and Andrew Schwab. Members of the Nomination and Remuneration Committee are Peter Fellner (Chairman), Bradley J. Bolzon, William Burns and James Shannon The term of office of the Board expires at the end of the Annual General Meeting following their election. In Turku, 7 February 2011 Biotie Therapies Corp. Timo Veromaa, President and CEO For further information, please contact: Virve Nurmi, Investor Relations Manager, Biotie Therapies Corp. tel. +358 2 274 8900, e-mail: virve.nurmi@biotie.com www.biotie.com Distribution: NASDAQ OMX Helsinki Ltd Main Media [HUG#1486221] |
|||
|